Page last updated: 2024-08-17

levodopa and dsp 4

levodopa has been researched along with dsp 4 in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19903 (18.75)18.7374
1990's1 (6.25)18.2507
2000's6 (37.50)29.6817
2010's6 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, T; Narabayashi, H; Nishi, K2
Gibson, CJ1
Hallman, H; Jonsson, G1
Schmidt, WJ; Srinivasan, J1
Archer, T; Fredriksson, A2
Barbanoj, M; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V1
Barbanoj, M; Gich, I; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V1
Aguilar, E; Barbanoj, M; Kulisevsky, J; Marin, C; Pérez, V; Rubio, A1
Feinstein, DL; Galea, E; McGuire, S; Polak, PE; Sharp, A; Simonini, MV1
Roczniak, W1
Björklund, A; Carta, M; Devoto, P; Rogers, JT; Shin, E1
Huang, C; Liu, J; Wang, HS; Wang, T; Wang, Y1
Babuśka-Roczniak, M; Brodziak-Dopierała, B; Cipora, E; Kwapuliński, J; Nowak, P; Oświęcimska, JM; Roczniak, W; Widuchowski, W1
Cao, LF; Chen, LH; Cheng, RX; Huang, Y; Liu, T; Luo, WF; Peng, XY; Wang, B; Zhou, FM1

Reviews

1 review(s) available for levodopa and dsp 4

ArticleYear
[A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Dopamine; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Parkinson Disease, Secondary; Pyridines

1987

Other Studies

15 other study(ies) available for levodopa and dsp 4

ArticleYear
Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa.
    Neuroscience letters, 1991, Feb-25, Volume: 123, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Benzylamines; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Endings; Neurotoxins; Norepinephrine

1991
Increase in mouse brain regional noradrenaline turnover after L-dopa administration.
    The Journal of pharmacy and pharmacology, 1988, Volume: 40, Issue:4

    Topics: Animals; Benzylamines; Brain; Levodopa; Male; Mice; Mice, Inbred Strains; Norepinephrine

1988
Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    European journal of pharmacology, 1984, Aug-17, Volume: 103, Issue:3-4

    Topics: Amines; Animals; Benzylamines; Catecholamines; Central Nervous System; Desipramine; Female; In Vitro Techniques; Levodopa; Male; Neurons; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pargyline; Rats; Rats, Inbred Strains; Synaptosomes

1984
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Behavioural brain research, 2004, May-05, Volume: 151, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Benzylamines; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Statistics, Nonparametric; Tyrosine

2004
Influence of noradrenaline denervation on MPTP-induced deficits in mice.
    Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:9

    Topics: Animals; Auditory Pathways; Behavior, Animal; Benzylamines; Brain Chemistry; Denervation; Dopamine Agents; Hippocampus; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Norepinephrine; Prefrontal Cortex; Substantia Nigra

2006
Postnatal iron overload destroys NA-DA functional interactions.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:2

    Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Benzylamines; Clonidine; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Iron Overload; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Norepinephrine

2007
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    European journal of pharmacology, 2007, Dec-08, Volume: 576, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Benzylamines; Brain; Caffeine; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

2007
Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:7

    Topics: Animals; Antiparkinson Agents; Benzylamines; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Levodopa; Male; Movement; Neurotoxins; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Recovery of Function; Synaptic Transmission; Time; Treatment Outcome

2009
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:10

    Topics: Animals; Benzylamines; Cognition Disorders; Dyskinesia, Drug-Induced; Levodopa; Locus Coeruleus; Male; Maze Learning; Medial Forebrain Bundle; Memory, Short-Term; Motor Activity; Neurodegenerative Diseases; Oxidopamine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substantia Nigra; Time Factors

2009
Increasing CNS noradrenaline reduces EAE severity.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2010, Volume: 5, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Animals; Astrocytes; Atomoxetine Hydrochloride; Benserazide; Benzylamines; Brain Chemistry; Central Nervous System; Cytokines; Dopamine Agents; Encephalomyelitis, Autoimmune, Experimental; Female; Glial Fibrillary Acidic Protein; Immunohistochemistry; Levodopa; Mice; Mice, Inbred C57BL; Norepinephrine; Propylamines; T-Lymphocytes

2010
Assessment of dopamine (DA) synthesis rate in selected parts of the rat brain with central noradrenergic lesion after administration of 5-HT3 receptor ligands.
    Postepy higieny i medycyny doswiadczalnej (Online), 2013, Jul-23, Volume: 67

    Topics: Adrenergic Neurons; Animals; Benzylamines; Brain Injuries; Brain Stem; Carboxy-Lyases; Dopamine; Frontal Lobe; Hypothalamus; Levodopa; Male; Morphine; Ondansetron; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT3; Thalamus

2013
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Experimental neurology, 2014, Volume: 257

    Topics: Adrenergic Agents; Adrenergic Neurons; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benzylamines; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Motor Activity; Nerve Degeneration; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Stereotyped Behavior

2014
L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
    Journal of neuroscience research, 2014, Volume: 92, Issue:12

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Benzylamines; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Microdialysis; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase

2014
The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:1

    Topics: Analgesics, Opioid; Animals; Autonomic Nervous System Diseases; Benzylamines; Biguanides; Brain Chemistry; Cerebellum; Dopamine; Hippocampus; Levodopa; Ligands; Male; Morphine; Neurotoxins; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists

2015
Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.
    Neural plasticity, 2016, Volume: 2016

    Topics: Animals; Benzylamines; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Norepinephrine; Oxidopamine; Pain; Parkinson Disease; Rats, Sprague-Dawley; Spinal Cord

2016